Research into ancient DNA sheds new light on cause of Multiple Sclerosis and other neurodegenerative diseases

Published on January 11, 2024

Research led by scientists at the Universities of Oxford, Cambridge, Copenhagen, Bristol and California (Berkeley) reveals the evolutionary origins of multiple sclerosis (MS). This new insight into the genetic architecture of this disease changes scientists’ view of its causes and has implications for its treatment, as well as paving the way for further investigations into other diseases.
Continue reading on website
Other news

First-in-human vaccine trial for deadly Nipah virus launched

January 11, 2024
First clinical trial participants received doses of the ChAdOx1 NipahB vaccine over the last week at University of Oxford. UK trial is first step to developing a vaccine against Nipah virus – a devastating disease mostly found in South-East Asia – that can be fatal in up to 75% of cases. The milestone clinical trial comes as the global health community marks the 25th anniversary of the first Nipah

COVID-19 vaccines found to be effective in reducing long COVID symptoms

January 11, 2024
A recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID.